Relmada Therapeutics RLMD

$ 2.81 -1.58%

Quarterly report 2024-Q3
added 11-07-2024

Relmada Therapeutics Cash and Cash Equivalents 2011-2024 | RLMD

Annual Cash and Cash Equivalents Relmada Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.09 M	5.4 M	44.4 M	2.5 M	36.3 M	2.43 M	1.71 M	8.5 M	22.5 M	25.6 M	3.52 M	1.77 M	21.9 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
44.4 M	21.9 K	12.2 M

Quarterly Cash and Cash Equivalents Relmada Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.48 M	2.09 M	1.34 M	4.09 M	6.7 M	14.5 M	28.9 M	5.4 M	42.5 M	37.3 M	44.9 M	44.4 M	11.4 M	4.67 M	3.8 M	2.5 M	7.54 M	2.5 M	2.5 M	36.3 M	36.3 M	36.3 M	36.3 M	2.43 M	887 K	2.43 M	887 K	5.94 M	4.68 M	5.94 M	4.68 M	4.71 M	6.22 M	4.71 M	6.22 M	15.1 M	19.2 M	15.1 M	19.2 M	31.4 M	27.4 M	31.4 M	27.4 M	3.52 M	3.95 M	1.56 M	1.37 M	1.77 M	8.95 K	8.95 K	4.78 K	21.9 K	3.01 K	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
44.9 M	3.01 K	12.5 M